Identification of patients at high cardiovascular risk: A critical appraisal of applicability of statistical risk prediction models

Methods of Information in Medicine

Volumn 40, Issue 1, 2001, Pages 6-11

  Dreau H ^a   Colombet, I ^a   Degoulet, P ^a   Chatellier, G ^a  

^a HÔTEL DIEU   (France)

Author keywords

Cardiovascular disease; Prediction; Risk models

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; HIGH RISK PATIENT; HYPERCHOLESTEROLEMIA; HYPERTENSION; OUTCOMES RESEARCH; POPULATION RESEARCH; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; REPRODUCIBILITY; RISK ASSESSMENT; STATISTICAL MODEL;

EID: 0035066849     PISSN: 00261270     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1634457     Document Type: Article

References (35)

1. Primary prevention of coronary heart disease: Guidance from Framingham: A statement for healthcare professionals from the AHA Task Force on Risk Reduction
2. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention
3. Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease
4. Management of raised blood pressure in New Zealand: A discussion document
5. What is "hypertension"?
6. Differences in generalists' and cardiologists' perceptions of cardiovascular risk and the outcomes of preventive therapy in cardiovascular disease
7. Clinical prediction rules. A review and suggested modifications of methodological standards
8. Understanding articles describing clinical prediction tools. Evidence based Medicine in Critical Care Group
9. Assessing the generalizability of prognostic information
10. Prediction of coronary heart disease mortality in Busselton, Western Australia: An evaluation of the Framingham, national health epidemiologic follow-up study, and WHO ERICA risk scores
11. Representativeness of the Framingham risk model for coronary heart disease mortality: A comparison with a national cohort study
12. Comparison of probability of stroke between the Copenhagen City Heart Study and the Framingham Study
13. Wine, alcohol, platelets, and the French paradox for coronary heart disease
14. Estimation of CHD risk in a French working population using a modified Framingham model
15. Do WHO-ISH guidelines identify high risk mild hypertensive patients?
16. Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach
17. A language for data analysis and graphics
18. An updated coronary risk profile. A statement for health professionals
19. Cardiovascular disease risk profiles
20. Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men
21. Multivariate prediction of coronary heart disease in the Western Collaborative Group Study compared to the findings of the Framingham study
22. Estimation of risk as a function of risk factors, II. - Application to the multivariate analysis of coronary heart disease in a middle aged male population
23. Intermittent claudication. A risk profile from The Framingham Heart Study
24. The Dundee coronary risk-disk for management of change in risk factors
25. Probability of stroke: A risk profile from the Framingham Study
26. Prediction of coronary heart disease in Europe; The 2nd report of the WHO-ERICA Project
27. Statistical methods for assessing observer variability in clinical measures
28. Randomised controlled trial of faccal-occult-blood screening for colorectal cancer
29. 14 Years of follow-up from the Edinburgh randomised trial of breast-cancer screening
30. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
31. Systematic review on the risk and benefit of different cholesterol-lowering interventions
32. On the use of a logistic risk score in predicting risk of coronary heart disease
33. Guidelines for antihypertensive therapy: Problems with a strategy based on absolute cardiovascular risk
34. Lifetime risk of developing coronary heart disease